Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Microvention, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Microvention, Inc.

Regulatory records
4
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Microvention, Inc.. It includes 2 original PMA approvals. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from May 30, 2018 to Oct 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code OPR appears in 2 of the 4 linked filings. The collection spans 2 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P170013, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 35 Enterprise, Aliso Viejo, CA, 92656. Recorded on P170032/S024, decision dated Oct 27, 2026.

Changes described in PMA records

P170032/S024: Woven EndoBridge (WEB) Aneurysm Embolization System

The FDA record P170032/S024, dated 2026-10-27, describes a 30-Day Notice for a process change covering manufacturer, sterilizer, packager or supplier. The stated purpose is approval for an alternate supplier of the resin used in the WEB detachment controller housing. The changed item is therefore the resin source for that housing, not the device's clinical use or labeling.

This supplement sits under the original PMA identifier P170032 for a MicroVention intrasaccular flow disruption device in the OPR product code. It is not a new approval of the whole WEB Aneurysm Embolization System. The source does not state resin identity, qualification data, or any conclusion about safety or clinical effectiveness; the reported purpose is regulatory, and independent proof of those outcomes is absent.

FDA approval-order wording

approval for an alternate supplier of the resin used in the WEB detachment controller housing

Oct 27, 2026 · 30-Day Notice

P170013/S013: Intraluminal Support Device LVIS/LVIS Jr./LVIS EVO

The FDA record shows a 30-day notice for P170013/S013, supplement reason listed as process change affecting manufacturer, sterilizer, packager or supplier. The stated purpose is to add automated robotic arms to the existing pickling and etching manufacturing processes for the LVIS/LVIS Jr./LVIS EVO intraluminal support device. The identifier ties this to PMA P170013, but the record is a supplement, not a new approval of the whole system, and it is a manufacturing notice rather than an original PMA.

The notice does not specify which manufacturing site is affected, the pickling or etching parameters involved, how the robotic arms integrate with existing steps, or what validation data were submitted. Nothing in the supplied fields reports safety or clinical effectiveness findings; the stated purpose of the change is distinct from proof of those outcomes.

The product is listed under product code QCA in the intracranial coil-assist stent category, with neurology as the specialty and MicroVention, Inc. as applicant.

FDA approval-order wording

to add automated robotic arms to the existing pickling and etchingmanufacturing processes

Sep 16, 2026 · 30-Day Notice

P170032: Woven EndoBridge (WEB) Aneurysm Embolization System

The FDA database entry records an original PMA approval for the Woven EndoBridge (WEB) Aneurysm Embolization System, an intrasaccular flow disruption device in the neurology specialty. The approval covers use in adults to embolize saccular intracranial wide neck bifurcation aneurysms in specified anterior and posterior circulation locations, with a dome diameter of 3 mm to 10 mm and a neck size of 4 mm or greater or a dome-to-neck ratio greater than 1 and less than 2.

The decision date is December 31, 2018, and the applicant is MicroVention, Inc. The entry lists no supplement type or supplement reason, so this record does not describe a change to a prior approval. The statement reports the approved scope of use; it does not by itself provide independent proof of safety or clinical effectiveness.

FDA approval-order wording

Approval for use in adults to embolize saccular intracranial wide neck bifurcation aneurysms located in the anterior (middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery (AComm) complex) and posterior (basilar apex) circulations, ranging in size from 3 mm to 10 mm in dome diameter, where the neck size is 4 mm or greater or the dome-to-neck ratio is greater than 1 and less than 2.

Dec 31, 2018

P170013: Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.

FDA approved PMA P170013 for the Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. from MicroVention, Inc. The approval statement describes the device as indicated for use with neurovascular embolization coils in patients 18 years or older for wide-neck saccular intracranial aneurysms, defined as neck width of 4 mm or greater or dome-to-neck ratio below 2, arising from a parent vessel with diameter between 2.0 mm and 4.5 mm.

The decision date is May 30, 2018, and the product code is QCA under the specialty of Neurology. The record does not include a supplement type or supplement reason, so no changed item or relationship to an earlier PMA is stated. The approval statement reports the device's indicated use but does not itself provide independent proof of safety or clinical effectiveness.

FDA approval-order wording

Approval for the Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. This device is indicated for use with neurovascular embolization coils in patients >= 18 years of age for the treatment of wide-neck (neck width >= 4 mm or dome to neck ratio < 2) saccular intracranial aneurysms arising from a parent vessel with a diameter >= 2.0 mm and <= 4.5 mm.

May 30, 2018

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Source information

Source updated Nov 9, 2026. Retrieved Nov 19, 2026.